R.PR
REGISTERED-PRINCIPAL REGISTER
05/10/2021
Voltar para busca
Dado oficial do USPTO
C CONSTANCE THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
63
Atualização mais recente
05/10/2021
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
10
Data de depósito
20/12/2018
Data de registro
05/10/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/10/2021
Última transação
05/10/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
17/02/2020
Primeiro uso no comércio
17/02/2020
Código do desenho
3
Tipo de titular
03
Localização do titular
San Francisco, CA, US
Examinador
BEN, LINDSEY HEATHER
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a "c" with alternating lines connected at hard angles followed by the words "constance therapeutics".
Titulares e representantes
Titulares
Constance Therapeutics, Inc.
Constance Therapeutics Inc
Representantes
R. Gwen Peterson Kilpatrick Townsend & Stockton LLP
Classificação técnica
Classes Nice
Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Vaporizers for medicinal purposes exclusively for use with products having a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; vaporizer cartridges for medicinal purposes containing cannabis extract having a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis being component parts of vaporizers for medicinal purposes; vaporizers for medicinal purposes containing cannabis extract having a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; vaporizer cartridges containing cannabis extract having a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and essential oils being component parts of vaporizers for medicinal purposes; vaporizers for medicinal purposes containing cannabis extract having a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and essential oils; vaporizer cartridges containing hemp extract having a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis being component parts of vaporizers for medicinal purposes; vaporizers for medicinal purposes containing hemp extract having a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Publicações
Histórico de despachos e eventos da marca no USPTO.
63 publicações encontradas
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
31/08/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
30/08/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26/08/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
25/08/2021
EX1G
SOU EXTENSION 1 GRANTED
25/08/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
25/08/2021
IUAF
USE AMENDMENT FILED
23/08/2021
EISU
TEAS STATEMENT OF USE RECEIVED
23/08/2021
NREV
NOTICE OF REVIVAL - E-MAILED
23/08/2021
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
23/08/2021
PETG
PETITION TO REVIVE-GRANTED
23/08/2021
PROA
TEAS PETITION TO REVIVE RECEIVED
23/08/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/08/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/08/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/08/2021
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
26/07/2021
ABN6
ABANDONMENT - NO USE STATEMENT FILED
26/07/2021
EXT1
SOU EXTENSION 1 FILED
22/06/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
22/12/2020
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
08/12/2020
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
08/12/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/10/2020
PUBO
PUBLISHED FOR OPPOSITION
27/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/10/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/09/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
22/09/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/09/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
22/09/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/08/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/02/2020
GNRT
NON-FINAL ACTION E-MAILED
27/02/2020
CNRT
NON-FINAL ACTION WRITTEN
27/02/2020
NREV
NOTICE OF REVIVAL - E-MAILED
11/02/2020
PETG
PETITION TO REVIVE-GRANTED
10/02/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
10/02/2020
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
09/12/2019
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
08/12/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/05/2019
GNRT
NON-FINAL ACTION E-MAILED
27/05/2019
CNRT
NON-FINAL ACTION WRITTEN
27/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/05/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/11/2018
GNRT
NON-FINAL ACTION E-MAILED
15/11/2018
CNRT
NON-FINAL ACTION WRITTEN
15/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/10/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/10/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/10/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/05/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/05/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/04/2018
GNRT
NON-FINAL ACTION E-MAILED
26/04/2018
CNRT
NON-FINAL ACTION WRITTEN
26/04/2018
DOCK
ASSIGNED TO EXAMINER
20/04/2018
DOCK
ASSIGNED TO EXAMINER
17/10/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/10/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/10/2017
NWAP
NEW APPLICATION ENTERED
05/10/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace C CONSTANCE THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.